CMC-SII20220527-01Matrix metalloproteinase in cells, tissues, and diseasesKimCheorl-HoMarch2023CMC-SII20220527-01.pdfCMC-SII20220308-01Pharmacological intervention of Neurodegenerative diseases: novel approaches BachurinSergeyMarch2021CMC-SII20220308-01.pdfCMC-SII20210714-01Kinase Inhibitors In Drug DiscoverySharmaVikasSeptember2021CMC-SII20210714-01.pdfCMC-SII20210607-01Nutraceuticals: from basic research to clinical
evidenceTrombettaDomenicoSeptember2021CMC-SII20210607-01.pdfCMC-SII20210311-01Current intellectual glance over nanoparticles in
cancer and neurodegenerative researchKamalMohammad AmjadGreigNigel HShenBairongBhattacharyaTanimaAugust2021CMC-SII20210311-01.pdfCMC-SII20210311-01Biomarkers and emerging drug targets in
neuropsychiatryMarazzitiDonatellaOctober2021CMC-SII20210311-01.pdfCMC-SII20210208-01Retinal degeneration: molecular mechanisms and
therapeutic strategiesShuXinhuaZhuLingSeptember2021CMC-SII20210208-01.pdfCMC-SII20210208-05Synthetic and biological procedures in antiviral
strategy: the present and the futureSALADINORaffaeleDecember2020CMC-SII20210208-05.pdfCMC-SII20210208-04Gut microbiota and chronic diseases and conditionsFranzaLauraCianciRossellaFebruary2021CMC-SII20210208-04.pdfCMC-SII20210208-03Natural product therapy on inflammation-associated
diseases by targeting NOD-like receptor protein 3 (NLRP3)
inflammasome: opportunity and challengeXuKangPourzandChararehJune2021CMC-SII20210208-03.pdfCMC-SII20210208-02Pathophysiological mechanisms of Cerebrovascular
diseasesAnnaBersanoMay2021CMC-SII20210208-02.pdfCMC-SII20210208-01Nucleoside and nucleotide analogues as potential
therapeuticsPawlowskaRozaChworosArkadiuszMarch2022CMC-SII20210204-01.pdfCMC-SII20210208-01Retinal degeneration: molecular mechanisms and
therapeutic strategiesShuXinhuaZhuLingFebruary2020CMC-SII20210204-01.pdfCMC-SII20210204-02Vascular aging and strokeSavopoulosChristosApril2020CMC-SII20210204-02.pdfCMC-SII20201106-01Organometallic and Coordination Complexes: Rational
design and fine-tuning of metalligand systems aimed at
versatile application in MedicineSobarzo-SánchezEduardoPérezMarianela SaldíasJune2021CMC-SII20201106-01.pdfCMC-SII20200914-01Trends in computational approaches for anti-cancer
researchKamalMohammad AmjadShenBairongHassanWaseemOctober2020CMC-SII20200914-01.pdfCMC-SII20200619-04Recent advances in the synthesis and biological
applications of metal/ metal oxidesRokhumDr. LalthazualaOctober2020CMC-SII20200619-04.pdfCMC-SII20200619-03The Role of PCSK9 in Atherogenesis and Inflammatory
DiseasesMontecuccoFabrizioCarboneFedericoOctober2020CMC-SII20200619-03.pdfCMC-SII20200619-02Targeting Cellular Signaling Pathways in Cancer by
Natural CompoundsKamalMohammad AmjadKhanMd. AsaduzzamanOctober2020CMC-SII20200619-02.pdfCMC-SII20200619-01Intelligent Platforms for Drug Design and
DevelopmentDingXiantingMay2020CMC-SII20200619-01.pdfCMC-SII20200612-02Computational Methods and Resources in Biological
and Medical DataLinHaoJanuary2021CMC-SII20200612-02.pdfCMC-SII20200612-01Cytokines in the Genesis and Treatment of
Autoimmune DiseasesYadollahpourAliJonesMylesJune2020CMC-SII20200612-01.pdfCMC-SII20200108-01Artificial Intelligence in Medicine: Disease
diagnosis, drug development and treatment personalizationTroisiJacopoOctober2020CMC-SII20200108-01.pdfCMC-SII20191001-06Natural Products as a Promising Therapeutic
Strategy to Target Cancer Stem CellsStanojkovicTatjanaJune2020CMC-SII20191001-06.pdfCMC-SII20191001-05Hot Natural Products for the Prevention and
Treatment of Diabetes Mellitus (DM)Popović-DjordjevićJelenaApril2020CMC-SII20191001-05.pdfCMC-SII20190820-01Natural Anti-Inflammatory Compounds as Drug
CandidatesWuYun-LongJanuary2020CMC-SII20190820-01.pdf